Gelderman, Monique P. and Simakova, Olga and Clogston, Jeffrey D. and Patri, Anil K. and Siddiqui, Sheena F. and Vostal, Alexander C. and Simak, Jan (2008) Adverse effects of fullerenes on endothelial cells: fullerenol C60(OH)24 induced tissue factor and ICAM-I membrane expression and apoptosis in vitro. International journal of nanomedicine, 3 (1). pp. 59-68. ISSN 1176-9114
Full text is not hosted in this archive but may be available via the Official URL, or by requesting a copy from the corresponding author.
We studied the effects of a C60 water suspension at 4 microg/mL (nC60) and the water soluble fullerenol C60(OH)24 at final concentrations of 1-100 microg/mL on human umbilical vein endothelial cells (HUVECs) in culture. We found that a 24 hr treatment of HUVECs with C60(OH)24 at 100 microg/mL significantly increased cell surface expression of ICAM-1(CD54) (67 +/- 4% CD54+ cells vs. 19 +/- 2 % CD540 cells in control; p < 0.001). In addition, this treatment induced the expression of tissue factor (CD142) on HUVECs (54 +/- 20% CD142+ cells vs 4 +/- 2% CD142+ cells in control; p = 0.008) and increased exposure of phosphatidylserine (PS) (29 +/- 2% PS+ cells vs. 12 +/- 5% PS+ cells in control; p < 0.001). Analysis of cell cycle and DNA fragmentation (TUNEL) showed that both nC60 and C60(OH)24 caused G1 arrest of HUVECs and C60(OH)24 induced significant apoptosis (21 +/- 2% TUNEL+ cells at 100 microg/mL of C60(OH)24 vs. 4 +/- 2% TUNEL+ cells in control; p < 0.001). We also demonstrated that both nC60 and C60(OH)24 induced a rapid concentration dependent elevation of intracellular calcium [Ca2+]i. This could be inhibited by EGTA, suggesting that the source of [Ca2+]i in fullerene stimulated calcium flux is predominantly from the extracellular environment. In conclusion, fullerenol C60(OH)24 had both pro-inflammatory and pro-apoptotic effects on HUVECs, indicating possible adverse effects of fullerenes on the endothelium.
|Uncontrolled Keywords:||apoptosis, flow-cytometry, fullerene, human-umbilical-vein-endothelial-cells, icam-1, tissue-factor|
|Subjects:||Biomedical Science > Nanotechnology for human health|
Risk > Environment, health and safety aspects of nanotechnology
|Deposited By:||Lesley Tobin|
|Deposited On:||07 Jan 2009 16:47|
|Last Modified:||19 Feb 2009 10:50|
Repository Staff Only: item control page